Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-part Study of Lembas Edge Evaluating Tolerability and Postprandial Glycemic Control

NCT07711288 is registered in ClinicalTrials.gov with Lembas as lead sponsor.

NCT NCT07711288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07711288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-part Study of Lembas Edge Evaluating Tolerability and Postprandial Glycemic Control
Lead sponsor
Lembas
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
January 31, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postprandial glycemic control, prediabetic overweight and obese adults